Headquarters
611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO, CA 94080-7066, US
SOUTH SAN FRANCISCO, CA, US
From the company
Jaya Biosciences is a privately held preclinical-stage life sciences company developing CNS-directed gene therapies for genetically defined neurodegenerative diseases, including Alzheimer's, Parkinson's, and frontotemporal dementia. Its lead therapy JB111 is an experimental CNS-directed AAV9-mediated PPT1 gene therapy being developed for Alzheimer's disease associated with PPT1 haploinsufficiency.
611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO, CA 94080-7066, US
Quantities, certifications, and timing.